This drug class, generally known as GLP-one agonists, contains semaglutide—approved as Ozempic for kind two diabetes and Wegovy for obesity—and tirzepatide—authorised as Mounjaro for diabetes and Zepbound for https://alexiaiuax119627.blogitright.com/profile